These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 8844816)

  • 1. Enhancement of rat liver cell foci development by combined treatment with heterocyclic amines at low doses.
    Ito N; Hasegawa R; Asakawa E; Hirose M; Imaida K; Hagiwara A
    Princess Takamatsu Symp; 1995; 23():251-9. PubMed ID: 8844816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic enhancement of hepatic foci development by combined treatment of rats with 10 heterocyclic amines at low doses.
    Hasegawa R; Miyata E; Futakuchi M; Hagiwara A; Nagao M; Sugimura T; Ito N
    Carcinogenesis; 1994 May; 15(5):1037-41. PubMed ID: 8200065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention by antioxidants of heterocyclic amine-induced carcinogenesis in a rat medium-term liver bioassay: results of extended and combination treatment experiments.
    Hirose M; Futakuchi M; Tanaka H; Orita SI; Ito T; Miki T; Shirai T
    Eur J Cancer Prev; 1998 Feb; 7(1):61-7. PubMed ID: 9511852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of synergism in hepatocarcinogenesis based on preneoplastic foci induction by 10 heterocyclic amines in the rat.
    Hasegawa R; Yoshimura I; Imaida K; Ito N; Shirai T
    Jpn J Cancer Res; 1996 Nov; 87(11):1125-33. PubMed ID: 9045941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of GST-P positive liver cell foci development by combined treatment of rats with five heterocyclic amines at low doses.
    Ito N; Hasegawa R; Shirai T; Fukushima S; Hakoi K; Takaba K; Iwasaki S; Wakabayashi K; Nagao M; Sugimura T
    Carcinogenesis; 1991 May; 12(5):767-72. PubMed ID: 2029739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carcinogenic risk of heterocyclic amines in combination - assessment with a liver initiation model.
    Hirata A; Tsukamoto T; Sakai H; Takasu S; Ban H; Imai T; Totsuka Y; Nishigaki R; Wakabayashi K; Yanai T; Masegi T; Tatematsu M
    Food Chem Toxicol; 2008 Jun; 46(6):2003-9. PubMed ID: 18331778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of carcinogenicity of daminozide, alone or in combination with its contaminant 1,1-dimethylhydrazine, in a medium-term bioassay.
    Cabral R; Hakoi K; Hoshiya T; Hasegawa R; Ito N
    Teratog Carcinog Mutagen; 1995-1996; 15(6):307-12. PubMed ID: 8732881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of hepatocarcinogenesis by combined administration of food-derived heterocyclic amines at low doses in the rat.
    Hasegawa R; Kato T; Hirose M; Takahashi S; Shirai T; Ito N
    Food Chem Toxicol; 1996; 34(11-12):1097-101. PubMed ID: 9119321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic enhancement of glutathione S-transferase placental form-positive hepatic foci development in diethylnitrosamine-treated rats by combined administration of five heterocyclic amines at low doses.
    Hasegawa R; Shirai T; Hakoi K; Takaba K; Iwasaki S; Hoshiya T; Ito N; Nagao M; Sugimura T
    Jpn J Cancer Res; 1991 Dec; 82(12):1378-84. PubMed ID: 1778761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary modulation of the carcinogenicity of the heterocyclic amines.
    Weisburger JH; Rivenson A; Kingston DG; Wilkins TD; Van Tassell RL; Nagao M; Sugimura T; Hara Y
    Princess Takamatsu Symp; 1995; 23():240-50. PubMed ID: 8844815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of glutathione S-transferase placental form-positive foci development in rat hepatocarcinogenesis by Chlorella pyrenoidosa.
    Takekoshi H; Mizoguchi T; Komasa Y; Chubachi H; Inoue Y; Imanishi H; Nakano M
    Oncol Rep; 2005 Aug; 14(2):409-14. PubMed ID: 16012723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in rats: dose-response studies.
    Shirai T; Tamano S; Sano M; Masui T; Hasegawa R; Ito N
    Princess Takamatsu Symp; 1995; 23():232-9. PubMed ID: 8844814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancing effects of phenobarbital and 3-methylcholanthrene on GST-P-positive liver cell foci development in a new medium-term rat liver bioassay using D-galactosamine.
    Kim HC; Lee YS; Nishikawa A
    J Toxicol Environ Health; 1997 Apr; 50(5):519-28. PubMed ID: 9140468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medium-term bioassays for carcinogenicity of chemical mixtures.
    Ito N; Imaida K; Hirose M; Shirai T
    Environ Health Perspect; 1998 Dec; 106 Suppl 6(Suppl 6):1331-6. PubMed ID: 9860889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of GST-P positive liver cell foci development by a medium-term carcinogenicity bioassay using repeated administration of D-galactosamine.
    Kim HC; Lee YS; Furukawa F; Nishikawa A; Takahashi M
    Cancer Lett; 1995 Nov; 98(1):71-6. PubMed ID: 8529208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-dependent formation of preneoplastic foci and DNA adducts in rat liver with 2-amino-3-methyl-9H-pyrido[2,3-b]indole (MeA alpha C) and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP).
    Hasegawa R; Takahashi S; Shirai T; Iwasaki S; Kim DJ; Ochiai M; Nagao M; Sugimura T; Ito N
    Carcinogenesis; 1992 Aug; 13(8):1427-31. PubMed ID: 1499093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low dose DDT inhibition of hepatocarcinogenesis initiated by diethylnitrosamine in male rats: possible mechanisms.
    Kushida M; Sukata T; Uwagawa S; Ozaki K; Kinoshita A; Wanibuchi H; Morimura K; Okuno Y; Fukushima S
    Toxicol Appl Pharmacol; 2005 Nov; 208(3):285-94. PubMed ID: 15885732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined supplementation of vanadium and beta-carotene suppresses placental glutathione S-transferase-positive foci and enhances antioxidant functions during the inhibition of diethylnitrosamine-induced rat liver carcinogenesis.
    Chattopadhyay MB; C B MK; Kanna PS; Ray RS; Roy S; Chatterjee M
    J Gastroenterol Hepatol; 2004 Jun; 19(6):683-93. PubMed ID: 15151625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modifying effects of chitin, chitosan and their related compounds on 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in a rat medium-term hepatocarcinogenesis model, and their post-initiation effects in a female rat 2-stage multi-organ carcinogenesis model.
    Kawabe M; Futakuchi M; Tamano S; Shirai T; Hirose M
    Food Chem Toxicol; 2008 Aug; 46(8):2758-63. PubMed ID: 18547703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effects of KAT-681, a liver-selective thyromimetic, on development of hepatocellular proliferative lesions in rats induced by 2-acetylaminofluorene and partial hepatectomy after diethylnitrosamine initiation.
    Hayashi M; Ohnota H; Tamura T; Kuroda J; Shibata N; Akahane M; Moriwaki H; Machida N; Mitsumori K
    Arch Toxicol; 2004 Aug; 78(8):460-6. PubMed ID: 15034639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.